Journey Medical Corporation
NASDAQ:DERM
3.73 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -3.853 | -29.628 | -43.994 | 5.283 | 3.625 | -221.54 | -303.261 | -89.084 | -78.399 | -31.875 |
| Depreciation & Amortization
| 3.855 | 4.365 | 2.56 | 1.516 | 1.264 | 0.555 | 0.339 | 0.123 | 0.072 | 0.047 |
| Deferred Income Tax
| 0 | 0 | 1.566 | -0.335 | 0.069 | -0.194 | 0 | -0.622 | 0.031 | 0.031 |
| Stock Based Compensation
| 2.606 | 4.425 | 2.466 | 0.153 | 0.24 | 29.843 | 20.703 | 0 | 5.132 | 1.643 |
| Change In Working Capital
| -1.655 | 6.187 | 14.709 | -2.232 | 3.465 | -154.403 | 202.257 | 57.662 | 97.764 | -1.542 |
| Accounts Receivables
| 12.551 | -5.38 | 0.768 | -5.022 | -10.492 | -5.672 | 21.348 | -21.4 | 7.3 | -7.3 |
| Inventory
| 3.953 | 1.744 | -8.458 | -0.547 | -0.179 | -8.37 | -271.889 | -174.203 | -104.48 | -91.024 |
| Accounts Payables
| -18.421 | 14.343 | 21.713 | -0.152 | 1.148 | 0.823 | 1.542 | 4.266 | 3.607 | 3.209 |
| Other Working Capital
| 0.262 | -4.52 | 0.686 | 3.489 | 12.988 | -141.184 | 451.256 | 248.999 | 191.337 | 93.573 |
| Other Non Cash Items
| 4.287 | 1.117 | 20.512 | 0.747 | 0.355 | 132.641 | -24.001 | -53.193 | -73.042 | 0.292 |
| Operating Cash Flow
| 5.24 | -13.534 | -2.181 | 5.132 | 9.018 | -213.098 | -103.963 | -74.111 | -48.442 | -31.404 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| 0 | -20 | -10 | -1.2 | -2.4 | -0.616 | -0.278 | -0.753 | -0.202 | -0.156 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 130.288 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | -319.94 | -302.432 | -252.175 | -60.276 | -109.324 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 363.328 | 278.58 | 122.64 | 57.875 | 0 |
| Other Investing Activites
| -5 | -20 | -10 | -1.2 | 0 | -56 | -80.3 | -130.288 | 0 | 0 |
| Investing Cash Flow
| -5 | -20 | -10 | -1.2 | -2.4 | -13.228 | -104.43 | -130.288 | -2.603 | -109.48 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -8.948 | 16.899 | 5.052 | -0.5 | -3.551 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 4.494 | -0.371 | 32.536 | 0.013 | 0 | 2.146 | 181.538 | 138.95 | 105.049 | 0.011 |
| Common Stock Repurchased
| 0 | -0.371 | 0 | 0 | 0 | 2.146 | 184.277 | 138.95 | 105.049 | 170.086 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.35 | -0.443 | 35.938 | 0.013 | 0 | 35.381 | 462.523 | 138.95 | 102.929 | 174.098 |
| Financing Cash Flow
| -4.804 | 16.456 | 53.016 | -0.487 | -3.551 | 35.381 | 462.523 | 138.95 | 102.929 | 174.098 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -22.144 |
| Net Change In Cash
| -4.564 | -17.078 | 40.835 | 3.445 | 3.067 | -190.945 | 254.13 | -65.449 | 51.884 | 11.07 |
| Cash At End Of Period
| 27.439 | 32.003 | 49.081 | 8.246 | 4.801 | 104.978 | 295.923 | 41.793 | 107.242 | 33.214 |